Le Lézard
Classified in: Health
Subject: RCL

Food Recall Warning (Allergen) - Certain Zabiha Halal brand and Maple Lodge Farms brand Chicken Wiener products recalled due to undeclared pea protein


Product photos are available: https://recalls-rappels.canada.ca/en/alert-recall/certain-zabiha-halal-brand-and-maple-lodge-farms-brand-chicken-wiener-products

OTTAWA, ON, July 21, 2022 /CNW/ -

Summary
Affected products

Brand

Product

Size

UPC

Codes

Zabiha Halal

Original Chicken Wieners

450 g   

0 67714 00203 4

All Best Before dates from
2022.JN.30 up to and
including 2022.SE.28

Maple Lodge Farms   

Original Chicken Wieners   

450 g

0 67714 00001 6

All Best Before dates from
2022.JN.30 up to and
including 2022.SE.28

Zabiha Halal

Corn Dog

1 kg

0 67714 00838 8

LOT 16522 (BBD 2023 06 14)   

LOT 16422 (BBD 2023 06 13)

LOT 13622 (BBD 2023 05 16)

LOT 12922 (BBD 2023 05 09)

LOT 12622 (BBD 2023 05 06)

Issue

The affected products are being recalled from the marketplace because they contain pea protein which is not declared on the label.

The recalled products have been sold nationally.

What you should do

Learn more:

Background

This recall was triggered by a consumer complaint.

There has been one reported reaction associated with the consumption of these products.

What is being done

The Canadian Food Inspection Agency (CFIA) is conducting a food safety investigation, which may lead to the recall of other products.

The CFIA is verifying that industry is removing recalled products from the marketplace.

SOURCE Canadian Food Inspection Agency (CFIA)


These press releases may also interest you

at 06:03
The IAMStm brand, proudly part of the Mars family of brands, announced today the launch of the IAMStm Puppy Hub and Kitten Hub, two online tools featuring expert knowledge and advice for new and soon-to-be pet parents. Each Hub will bring...

at 06:00
Today, TELUS Health announced a collaboration with Nova Scotia Health (NSH) to enable residents of Nova Scotia to access their primary care information through the YourHealthNS app. This health data interoperability initiative marks the first...

at 05:30
The global Digital Healthcare Market, valued at $220.10 billion in 2024, is on a trajectory of rapid expansion, with projections indicating it will soar to $836.10 billion by 2031, growing at a compound annual growth rate (CAGR) of 21% from 2024 to...

at 05:09
Medical imaging IT and cybersecurity company Sectra (STO: SECT B) is publishing its Annual Report and Sustainability Report for the 2023/2024 fiscal year today. This report also includes the Corporate Governance Report for the same period. The...

at 03:20
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...



News published on and distributed by: